Breaking the redundancy: TAZ outperforms YAP1 in GIST progression
Irène Pezzati, César Serrano, Éric Vivès, Frédéric Chibon, Sandrine Faure, Pascal de Santa Barbara, Sébastien Deshayes, Prisca Boisguérin
This study shows that TAZ, not YAP1, is more critical for GIST progression and that targeting TAZ could be a better therapeutic strategy.
bioRxiv · Sep 2, 2025 · PreprintCancer Biology